Gabriela Guillen
Overview
Explore the profile of Gabriela Guillen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heinz A, Ciuffolotti M, Merks J, Schonstein A, Minard-Colin V, Fuchs J, et al.
Pediatr Blood Cancer
. 2024 Dec;
72(3):e31476.
PMID: 39655886
Background: Patients with alveolar rhabdomyosarcoma (ARMS) with regional lymph node involvement (N1) are defined as "very-high-risk rhabdomyosarcoma" in Europe. Different chemotherapy regimens were used in European study protocols. Methods: Patients...
2.
Lopez-Fernandez S, Molino J, Soler-Palacin P, Mendoza-Palomar N, Uria Oficialdegui M, Martos Rodriguez M, et al.
Pediatr Surg Int
. 2024 Oct;
40(1):263.
PMID: 39367968
Purpose: Invasive Pulmonary Fungal Infections (IPFIs) represent a diagnostic and therapeutic challenge. The exact role of surgery is not well defined. This study analyzes our experience with surgical treatment of...
3.
Mena R, Guillen G, Lopez-Fernandez S, Martos Rodriguez M, Ruiz C, Montaner-Ramon A, et al.
Eur J Pediatr Surg
. 2024 Sep;
PMID: 39348873
Background: Necrotizing enterocolitis (NEC) is one of the main causes of acute abdomen in neonates. Surgical treatment entails important morbidity and mortality and conservative management, when possible, offers better outcomes....
4.
Molino J, Guillen G, Khan H, Lopez Fernandez S, Martos Rodriguez M, Rocha O, et al.
Pediatr Surg Int
. 2024 Jul;
40(1):171.
PMID: 38958763
Purpose: Split abdominal wall muscle flap (SAWMF) is a technique to repair large defects in congenital diaphragmatic hernia (CDH). A possible objection to this intervention could be any associated abdominal...
5.
De Salvo G, Del Bianco P, Minard-Colin V, Chisholm J, Jenney M, Guillen G, et al.
Cancer
. 2024 Feb;
130(13):2351-2360.
PMID: 38400828
Background: The objective of this study was to investigate the role of clinical factors together with FOXO1 fusion status in patients with nonmetastatic rhabdomyosarcoma (RMS) to develop a predictive model...
6.
Garcia-Aguilar P, Maiz N, Rodo C, Garcia-Manau P, Arevalo S, Molino J, et al.
Acta Obstet Gynecol Scand
. 2023 May;
102(7):883-890.
PMID: 37194337
Introduction: The primary aim of the study was to identify risk factors associated with fetal or neonatal loss, neonatal morbidity, and the need for surgery in fetuses diagnosed with an...
7.
Cadaval C, Molino J, Guillen G, Lopez Fernandez S, Hierro C, Martos Rodriguez M, et al.
Eur J Pediatr Surg
. 2023 Apr;
34(4):301-305.
PMID: 37054980
Background: Thoracoscopic repair of esophageal atresia (EA) with tracheoesophageal fistula (TEF) is becoming an increasingly widespread technique; there is still controversy about its indication in certain patients. Our objective is...
8.
Zarzosa P, Garcia-Gilabert L, Hladun R, Guillen G, Gallo-Oller G, Pons G, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765685
Aberrant activation of the Hedgehog (Hh) signalling pathway is known to play an oncogenic role in a wide range of cancers; in the particular case of rhabdomyosarcoma, this pathway has...
9.
Navarro N, Molist C, Sansa-Girona J, Zarzosa P, Gallo-Oller G, Pons G, et al.
Cell Mol Life Sci
. 2022 Oct;
79(11):546.
PMID: 36221013
The majority of current cancer therapies are aimed at reducing tumour growth, but there is lack of viable pharmacological options to reduce the formation of metastasis. This is a paradox,...
10.
Abele M, Bajciova V, Wright F, Behjati S, Voggel S, Schneider D, et al.
Eur J Cancer
. 2022 Sep;
175:19-30.
PMID: 36087394
Background: Primary lung carcinoma is an exceptionally rare childhood tumour, as per definition of the European Cooperative Study Group on Paediatric Rare Tumours (EXPeRT), with an incidence of 0.1-0.2/1,000,000 per...